Skip to content
Dose Brief
Menu

Briefs · page 4 of 14

Every provider in the ranking, scored

Each GLP-1 telehealth provider we track, graded on the Brief Score — price stability, supply reliability, transparency and access.

Showing 121–160 of 546. Most recent verification in the ranking: .

Grade C and below

Tracked and scored — read the caveats.

Brief Scores are our editorial judgment per the methodology; facts reflect each provider's public disclosures at last check. A commission never changes a score, and it never softens what we write about a provider. What it does move is position: this index runs in ranking order, and providers we have a commercial relationship with sit ahead of providers we do not. Weigh the write-up, not the slot — see our disclosure. Not medical advice.

The desk's No. 121 · 73/100

NovoCare Pharmacy

Novo Nordisk's first-party direct-to-consumer pharmacy for branded Wegovy (semaglutide).

Semaglutide
From $349/mo (2.4 mg dose, brand-name)
Tirzepatide
Not disclosed
Visit NovoCare Pharmacy ↗
Full brief →Ad disclosure — we may earn a commission.

Shopping on price?

See every provider with its price direction and the note behind it.

Open the ranking →